Eli Lilly News Monitoring
-
Published on 07:03 GMTSource: Barron's - Neutral
-
Published on 05:26 GMT
Eli Lilly's Zepbound Receives FDA Approval For Obesity-Linked Sleep Apnea Drug
On Friday, the U.S. Food and Drug Administration approved Eli Lilly and Co.’s LLY weight loss drug Zepbound for treating sleep apnea What Happened: The FDA’s decision makes Zepbound the first approved drug treatment for patients with obesity and moderate- …
Source: Benzinga - Neutral -
Published on Dec 21, 2024
Federal officials approve use of Eli Lilly obesity drug Zepbound for treating sleep apnea
The Food and Drug Administration on Friday approved the use of Eli Lilly medicine Zepbound, already prescribed for weight loss, as a treatment for sleep apnea in obese patients. The active chemical in Zepbound, tirzepatide, is also prescribed for treating …
Source: The Washington Times - Right-wing -
Published on Dec 21, 2024
USFDA approves Eli Lilly weight loss treatment Zepbound for obstructive sleep apnea
Indianapolis: Eli Lilly and Company has announced the U.S. Food and Drug Administration (FDA) has approved Zepbound (tirzepatide) as a prescription medicine for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. Zepbound may help …
Source: Medical Dialogues - Uncategorized -
Published on Dec 21, 2024
Is Now a Good Time to Buy the Dip in Eli Lilly Stock?
Since Eli Lilly reported third-quarter earnings on Oct. 30, its shares have had a prolonged sell-off. Since pharmaceutical giant Eli Lilly (LLY 1.35%) reported earnings for the third quarter on Oct. 30, shares have been punished by investors. As of this …
Source: myMotherLode - Label Pending -
Published on Dec 21, 2024
Eli Lilly given US approval to treat sleep disorder with weight-loss drug
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. US regulators have approved Eli Lilly’s Zepbound to treat adults with both sleep apnoea and obesity, marking a victory for the …
Source: The Financial Times - Neutral -
Published on Dec 21, 2024
Eli Lilly's obesity drug Zepbound gains approval to treat sleep apnea
The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved to treat patients with obstructive sleep apnea, said …
Source: USA Today - Neutral -
Published on Dec 21, 2024
STAT+: Eli Lilly’s obesity drug Zepbound approved to treat sleep apnea in U.S.
The Food and Drug Administration on Friday cleared Eli Lilly’s obesity drug Zepbound as the first treatment for a common sleep disorder in the U.S. Zepbound, whose scientific name is tirzepatide, has now been specifically approved for patients with both …
Source: STAT - Massachusetts - Neutral -
Published on Dec 21, 2024
FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea
Posted/updated on: December 20, 2024 at 6:17 pm Scott Olson/Getty Images(NEW YORK) -- The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with …
Source: KTBB - Texas - Label Pending -
Published on Dec 20, 2024
Eli Lilly's Obesity Drug Wins Approval In Sleep Apnea
Eli Lilly (LLY) gained Food and Drug Administration approval late Friday for its weight-loss drug, Zepbound, as a treatment for obstructive sleep apnea. ↑ X NOW PLAYING The Weight-Loss Drug Market Is Hot. Which Medical Stock Will Win The Battle For …
Source: Investor's Business Daily - Neutral -
Published on Dec 20, 2024
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
The Food and Drug Administration approved Eli Lilly's blockbuster weight loss drug Zepbound for treating patients with the most common sleep-related breathing disorder. The weekly injection is now cleared for patients with obesity and moderate-to- …
Source: NBC Connecticut - Neutral -
Published on Dec 20, 2024
The FDA just approved Eli Lilly's Zepbound for sleep apnea — and Medicare coverage could be next
Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug Administration (FDA) as the first prescription drug to help alleviate moderate-to-severe obstructive sleep apnea (OSA) for adults with …
Source: Quartz - Label Pending -
Published on Dec 21, 2024
The FDA just approved Eli Lilly's Zepbound for sleep apnea — and Medicare coverage could be next
Source: Quartz - Label Pending -
Published on Dec 20, 2024
Eli Lilly, Avago lead market cap stock movers this Friday
Friday's market has seen notable movements across various stocks, with significant activity in both the mega-cap and large-cap categories. Eli Lilly and Co (LLY) and Avago Technologies (NASDAQ:AVGO) are among the stocks experiencing upward trends, …
Source: Investing - Neutral -
Published on Dec 20, 2024
Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up
Today's sell-off in Novo Nordisk may be the buying opportunity you've been waiting for. Bad news for Novo Nordisk (NVO -16.52%) Friday was good news for Eli Lilly (LLY 4.04%) and Viking Therapeutics (VKTX 6.34%), its two main rivals in the field of …
Source: myMotherLode - Label Pending -
Published on Dec 20, 2024
FDA confirms end of Eli Lilly’s tirzepatide shortage after re-evaluation
The US Food and Drug Administration (FDA) has stood by an earlier decision confirming that the tirzepatide shortage is over. The end of the shortage means that pharmacies making compounded versions of the drug will have to stop production. FDA-approved …
Source: Pharmaceutical Technology - Neutral -
Published on Dec 19, 2024
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortage
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters The Food and Drug Administration on Thursday said the active ingredient in Eli Lilly's weight loss drug Zepbound is …
Source: CNBC - Neutral -
Published on Dec 20, 2024
FDA Says Eli Lilly's Weight Loss Drug No Longer In Short Supply
(MENAFN- Baystreet) The U.S. Food and Drug Administration (FDA) says that the active ingredient in Eli Lilly's (LLY) weight loss drug Zepbound is no longer in short supply. The news is positive for Eli Lilly as it means that compounding pharmacies will …
Source: MENAFN - Uncategorized -
Published on Dec 20, 2024
FDA reaffirms decision to erase Eli Lilly's tirzepatide from shortage list, halting future flow of knockoffs
The FDA has doubled down on its decision to remove Eli Lilly’s tirzepatide from its list of products that are in shortage. The agency’s move means that compounding pharmacies will have to halt production of their knockoff versions of diabetes drug Mounjaro …
Source: Fierce Pharma - Neutral
Featured Releases
-
Published on December 20, 2024 - 20:57 GMT
Regional Health Directorate of Ucayali distinguished Ocho Sur for Its Contribution to Healthcare in Local Communities
Ocho Sur was honored by DIRESA Ucayali for improving healthcare access and addressing health issues in remote communities of Nueva Requena and Curimaná PUCALLPA, UCAYALI, PERU, December 20, 2024 /EINPresswire.com/ -- The Regional Directorate of …
Distribution channels: Agriculture, Farming & Forestry Industry, Business & Economy ... -
Published on December 20, 2024 - 16:15 GMT
Comprehensive Healthcare Leader Joins NAMI Washington Board of Directors
YAKIMA, Wash., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Comprehensive Healthcare is pleased to announce that Cassidy Brown, director of marketing and communications, has been appointed to the National Alliance of Mental Illness (NAMI) Washington Board of …
Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
-
Published on December 19, 2024 - 23:30 GMT
Precision Medicine Adoption: A Key Driver Transforming the Artificial Intelligence in Healthcare Market 2024
The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—for a limited time only! LONDON, GREATER LONDON, UNITED KINGDOM, December 20, 2024 /EINPresswire.com/ -- The Business Research Company’s …
Distribution channels: Business & Economy, Companies ... -
Published on December 19, 2024 - 11:00 GMT
Healthcare Art Consulting & Quality Art House (HAC & QAH) Announce Release of January 2025 Digital Signage Graphics
Healthcare Art Consulting & Quality Art House (HAC & QAH) Announce Release of January 2025 Digital Signage Graphics DALLAS, TX, UNITED STATES, December 19, 2024 /EINPresswire.com/ -- Healthcare Art Consulting & Quality Art House ( …
Distribution channels: Building & Construction Industry, Education ...
-
Published on December 19, 2024 - 13:00 GMT
Patient Monitoring Devices Market to Hit USD 93.53 Bn by 2032, Fueled by Tech Advancements & Rising Healthcare Demand
"Expanding Innovations and Rising Demand Drive Growth in the Global Patient Monitoring Devices Market" AUSTIN, TX, UNITED STATES, December 19, 2024 /EINPresswire.com/ -- The Patient Monitoring Devices Market was valued at USD 48.03 …
Distribution channels: Healthcare & Pharmaceuticals Industry ... -
Published on December 19, 2024 - 23:29 GMT
Care Synergy and RCC Medical Equipment Announce Plans to Form Healthcare Joint Venture
Denver, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Care Synergy and RCC Medical Equipment Co. have agreed to form a joint-venture partnership to provide enhanced healthcare services throughout the Colorado Front Range region. Together, Care Synergy, a leading …
Distribution channels: -
Published on December 19, 2024 - 22:00 GMT
embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
PARSIPPANY, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 15, 2025 at 7:30 a.m. PT / 10:30 a.m …
Distribution channels: -
Published on December 19, 2024 - 21:00 GMT
Advancing Healthcare Excellence: The Dr. Wade Newman Grant for Healthcare Students Launches to Inspire Future Leaders in ...
BELLEFONTE, Pa., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Dr. Wade Newman, a distinguished dental professional and passionate advocate for accessible healthcare, proudly announces the launch of The Dr. Wade Newman Grant for Healthcare Students. This prestigious …
Distribution channels:
Online News Monitoring Made Simple
Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.
News by Country & by Industry
Track news across more than 5,000 sources by country or industry or search our real-time news index.
News Alerts & News Feeds
News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.
Submit News
Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.
World Media Directory
This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 12/19/2024
Healthcare & Pharmaceuticals Industry Press Releases
-
Published on December 22, 2024 - 15:50 GMT
Kaleafa Cannabis Dispensary Aberdeen Enhances Inventory with Diverse Cannabis Products
New selections include top brands and premium strains, offering Aberdeen customers a wider variety of high-quality cannabis products to choose from. ABERDEEN , WA, UNITED STATES, December 22, 2024 /EINPresswire.com/ -- Kaleafa Cannabis …
Distribution channels: Consumer Goods, Culture, Society & Lifestyle ... -
Published on December 22, 2024 - 15:40 GMT
GCRC CEO Mike Robinson Invited As Guest Keynote for American Cancer Research Conference 2025
Global Cannabinoid Research Center (GCRC) and Nanobles Corporation have merged, creating a powerhouse entity led by Mike Robinson, a Multiple Cancer Survivor SANTA BARBARA, CA, UNITED STATES, December 22, 2024 /EINPresswire.com/ -- Mike Robinson …
Distribution channels: Companies, Culture, Society & Lifestyle ... -
Published on December 21, 2024 - 23:09 GMT
Combination of Addiction and Mental Health Treatment Improving Recovery Results
Integrated treatment programs combining addiction and mental health care deliver superior outcomes, reducing relapse rates and transforming recovery practices. NEW ORLEANS, LA, UNITED STATES, December 21, 2024 /EINPresswire.com/ -- In a …
Distribution channels: Business & Economy, Companies ... -
Published on December 21, 2024 - 19:37 GMT
Scottsdale Practice Embraces Advanced Technology to Shape the Future of Cosmetic Dentistry
Transform your smile with Arizona's leading cosmetic dental experts. SCOTTSDALE, AZ, UNITED STATES, December 21, 2024 /EINPresswire.com/ -- The integration of advanced technology in cosmetic dentistry is reshaping the patient experience and …
Distribution channels: Beauty & Hair Care, Business & Economy ... -
Published on December 21, 2024 - 19:16 GMT
Butterfly Wellness Introduces Shammah: The World's First Psychodermatology Chatbot
This press release is about Butterfly Wellness' Launch of Shammah, the Uk's First Psychodermatology Chatbot for Holistic Skin and Mental Health Support. LONDON, LONDON, UNITED KINGDOM, December 21, 2024 /EINPresswire.com/ -- Butterfly …
Distribution channels: Beauty & Hair Care, Business & Economy ... -
Published on December 21, 2024 - 18:33 GMT
Iowa Gov. Kim Reynolds Announces Higley Partners to Receive $2 Million For Addiction Center
Historic Cedar Rapids property to transform into Radix Recovery, a 68-bed addiction center, with $2 million state grant and local partnerships. CEDAR RAPIDS, CO, UNITED STATES, December 21, 2024 /EINPresswire.com/ -- Throughout the decades the …
Distribution channels: Banking, Finance & Investment Industry, Building & Construction Industry ... -
Published on December 21, 2024 - 15:39 GMT
SurveySlack Launches New Survey Platform to Maximize User Engagement and Feedback
SurveySlack simplifies survey creation with customizable templates, AI-driven questions, real-time analytics, and branching logic to boost engagement. AHMEDABAD, GUJARAT, INDIA, December 21, 2024 /EINPresswire.com/ -- SurveySlack has launched a …
Distribution channels: Business & Economy, Companies ... -
Published on December 21, 2024 - 14:04 GMT
Smile4EverMexico Announces New Single-Visit Tooth Restoration Option
TIJUANA, MEXICO, December 21, 2024 /EINPresswire.com/ -- Smile4EverMexico, a clinic specializing in border dentistry, is pleased to announce it has introduced a new service in dental care: complete tooth restoration treatments that can be …
Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ... -
Published on December 22, 2024 - 01:58 GMT
Dr. Yorell Manon Matos Launches Transformative Healthcare Education Grant to Cultivate Next Generation of Medical ...
SIOUX FALLS, S.D., Dec. 21, 2024 (GLOBE NEWSWIRE) -- Distinguished hand surgeon Dr. Yorell Manon-Matos announces the establishment of a groundbreaking academic grant program designed to nurture emerging talent in healthcare education. The Dr. Yorell Manon …
Distribution channels: -
Published on December 22, 2024 - 01:45 GMT
Dr. Kent Scheff Announces the Launch of the Dr. Kent Scheff Scholarship for Sports Medicine
ST. PAUL, Minn., Dec. 21, 2024 (GLOBE NEWSWIRE) -- Dr. Kent Scheff, a renowned physician specializing in Primary Care Sports Medicine, is pleased to announce the launch of the Dr. Kent Scheff Scholarship for Sports Medicine, an annual scholarship program …
Distribution channels: Consumer Goods, Healthcare & Pharmaceuticals Industry ... -
Published on December 21, 2024 - 13:45 GMT
NASP Tells Congress and the Incoming Trump Administration: Pharmacies and Patients Can’t Continue to Wait for PBM ...
Washington, DC, Dec. 21, 2024 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy issued the following statement: As the non-profit trade organization representing specialty pharmacies that support patients with significant and complex …
Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ... -
Published on December 20, 2024 - 22:32 GMT
Heavenly Spa By Westin™ at The Westin® Fort Lauderdale Beach Resort Completes an Elaborate Renovation
Spa Enthusiasts Can Enjoy a Wellness Journey Inspired by Serene Destinations Worldwide with New Treatments, an Infrared Sauna and Exclusive Retail Products FORT LAUDERDALE, FL, UNITED STATES, December 20, 2024 /EINPresswire.com/ -- Heavenly Spa …
Distribution channels: Beauty & Hair Care, Business & Economy ... -
Published on December 20, 2024 - 22:30 GMT
Lucid Dreaming Devices Market Forecasted to Reach USD 196.8 Million by 2034, Growing at a CAGR of 5.1% | TMR
The lucid dreaming devices market is gaining traction as individuals seek tools to control and enhance their dream experiences for wellness or research. WILMINGTON, DE, UNITED STATES, December 21, 2024 /EINPresswire.com/ -- The global lucid …
Distribution channels: Healthcare & Pharmaceuticals Industry ... -
Published on December 20, 2024 - 22:15 GMT
Medical Biomimetics Market Expected to Reach USD 19.3 Billion by 2034, With a CAGR of 6.8% |Transparency Market Research
The medical biomimetics market is advancing as biomimetic technologies offer solutions for tissue regeneration and healing in medical applications. WILMINGTON, DE, UNITED STATES, December 21, 2024 /EINPresswire.com/ -- The global medical …
Distribution channels: Healthcare & Pharmaceuticals Industry ... -
Published on December 20, 2024 - 22:00 GMT
Lymphedema Diagnostics Market to Reach USD 70.7 Million by 2034, Growing at a CAGR of 4.8% |Transparency Market Research
The lymphedema diagnostics market is expanding with innovative solutions for early detection and management of this chronic condition. WILMINGTON, DE, UNITED STATES, December 21, 2024 /EINPresswire.com/ -- The global lymphedema diagnostics …
Distribution channels: Healthcare & Pharmaceuticals Industry ... -
Published on December 20, 2024 - 21:30 GMT
Patient Monitoring and Ultrasound Devices Display Market Projected to Exceed USD 10.6 Billion by 2034 | TMR
The market for patient monitoring and ultrasound devices display is growing with advancements in real-time health monitoring and diagnostics WILMINGTON, DE, UNITED STATES, December 21, 2024 /EINPresswire.com/ -- The global patient monitoring and …
Distribution channels: Healthcare & Pharmaceuticals Industry ... -
Published on December 20, 2024 - 21:01 GMT
Catarina Malmrot's new book, Secrets of Sustainable Leadership, reaches #1 International Bestseller Status
Leadership Expert Catarina Malmrot Shares Her Holistic Approach to Quality Management and Leadership STOCKHOLM, SWEDEN, December 20, 2024 /EINPresswire.com/ -- Catarina Malmrot’s latest book, Secrets of Sustainable Leadership: A Holistic …
Distribution channels: Companies, Conferences & Trade Fairs ... -
Published on December 20, 2024 - 21:00 GMT
Glaucoma Treatment Market 2034: FDA Approval, Clinical Trials, Medication, Companies by DelveInsight
Glaucoma companies are Allergan, Santen Pharmaceutical, D.Western Therapeutics Institute, Kowa Ltd., Alcon, Senju Pharmaceuticals, Otsuka Pharmaceuticals, ETC ALBANY, NY, UNITED STATES, December 20, 2024 /EINPresswire.com/ -- DelveInsight's …
Distribution channels: Healthcare & Pharmaceuticals Industry ... -
Published on December 20, 2024 - 20:57 GMT
Regional Health Directorate of Ucayali distinguished Ocho Sur for Its Contribution to Healthcare in Local Communities
Ocho Sur was honored by DIRESA Ucayali for improving healthcare access and addressing health issues in remote communities of Nueva Requena and Curimaná PUCALLPA, UCAYALI, PERU, December 20, 2024 /EINPresswire.com/ -- The Regional Directorate of …
Distribution channels: Agriculture, Farming & Forestry Industry, Business & Economy ... -
Published on December 20, 2024 - 20:55 GMT
"Why Am I So Tired?” Quiz Launched by Nonprofit to Provide Insights Into Fatigue Causes
After a successful pilot phase, NHJI is launching the online tiredness test, offering free access to help individuals with persistent fatigue. TORONTO, ONTARIO, CANADA, December 20, 2024 /EINPresswire.com/ -- The New Health Journal Institute (“ …
Distribution channels: Companies, Consumer Goods ...
Healthcare & Pharmaceuticals Events
No event was found.
- Track news from thousands of sources
- Submit news sources for inclusion in our news tracking algorithm
- Build your own customized email newsletters
- Use of our RSS Feeds
- Includes a complimentary EIN Presswire account plus 1-free release
- Uncluttered & advertising free news pages